Literature DB >> 28988039

Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic epithelium.

Maia Marin1, Ravi Holani2, Chaitanya B Shah3, Anselmo Odeón4, Eduardo R Cobo5.   

Abstract

Cathelicidin are innate antimicrobial peptides with broad immunomodulatory functions; however, their role in regulating intestinal defenses is not well characterized. This study aimed to investigate the role of cathelicidin modulating expression of Toll-like receptors (TLRs) 4 and 9 in colonic epithelium in response to bacterial patterns. We demonstrated herein that intestinal epithelial cells, when primed by bacterial lipopolysaccharide (LPS), responded to cathelicidin by increased transcription and protein synthesis of TLR4. This cathelicidin-induced response required the interaction of LPS-TLR4 and activation of MAPK signalling pathways. However, cathelicidin blocked TLR9 responses induced by TLR9 ligand CpG oligodeoxynucleotide (CpG ODN) in these colonic epithelial cells. Modulations of TLRs triggered by cathelicidin in intestinal epithelium occurred mainly in the apical compartment of intestinal cells. Activation of TLR4 by ligands in combination with cathelicidin promoted CXCL8 chemokine secretion and epithelial antimicrobial defenses against Escherichia coli. We concluded that cathelicidin selectively modulated synthesis of TLR4 and 9 in intestinal epithelium, but only when cells were exposed to virulence factors, mostly from apical surfaces. Enhanced TLR4 expression promoted by cathelicidin in intestinal epithelium may be crucial for controlling enteric infectious diseases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; Cathelicidin; Escherichia coli; Intestinal epithelium; Toll-like receptor

Mesh:

Substances:

Year:  2017        PMID: 28988039     DOI: 10.1016/j.molimm.2017.09.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Authors:  Ross John Porter; Caroline Andrews; Daniel Paul Brice; Scott Kenneth Durum; Mairi Hall McLean
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

2.  Cathelicidins Mitigate Staphylococcus aureus Mastitis and Reduce Bacterial Invasion in Murine Mammary Epithelium.

Authors:  Paloma Araujo Cavalcante; Cameron G Knight; Yi-Lin Tan; Ana Paula Alves Monteiro; Herman W Barkema; Eduardo R Cobo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

3.  Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in macrophages.

Authors:  Karina M Cirone; Priyoshi Lahiri; Ravi Holani; Yi Lin Tan; Rakel Arrazuria; Jeroen De Buck; Herman W Barkema; Eduardo R Cobo
Journal:  Cell Tissue Res       Date:  2019-09-02       Impact factor: 5.249

Review 4.  Cathelicidins Modulate TLR-Activation and Inflammation.

Authors:  Maaike R Scheenstra; Roel M van Harten; Edwin J A Veldhuizen; Henk P Haagsman; Maarten Coorens
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

5.  Sequence edition of single domains modulates the final immune and antimicrobial potential of a new generation of multidomain recombinant proteins.

Authors:  Elena Garcia-Fruitós; Anna Arís; Ramon Roca-Pinilla; Ravi Holani; Adrià López-Cano; Cristina Saubi; Ricardo Baltà-Foix; Eduardo R Cobo
Journal:  Sci Rep       Date:  2021-12-10       Impact factor: 4.379

6.  Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production.

Authors:  Ravi Holani; Anshu Babbar; Graham A D Blyth; Fernando Lopes; Humberto Jijon; Derek M McKay; Morley D Hollenberg; Eduardo R Cobo
Journal:  Gut Microbes       Date:  2020-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.